The largest differences in expression between immune high TN and HR + HER2− tumors were that fibroblasts, specifically mCAF and vCAF that are associated with worse prognosis in breast cancer and were highest in HR + HER2− tumors while expression of TH1 and TH2 genes were highest in TN tumors. This evidence concerns the gene HCFC1 and breast cancer.